This is supported by the observations that TIPRL knockdown inhibited survival and stemness efficacies of HCC/liver cancer cells via the reduction of autophagy, as well as the strong associations between levels of TIPRL, LC3 and CD133 in HCC and liver cancer tissues. The gene discussed is MAP1LC3A; the disease is hepatocellular carcinoma.